Peri: The Innovative Wearable Revolutionizing Perimenopause Symptom Management

Introducing Peri: A Game Changer for Women's Health

In a groundbreaking move towards enhancing women's health, IdentifyHer has unveiled Peri, the world's first wearable specifically engineered to detect and decode symptoms associated with perimenopause. Launching for pre-orders in the United States ahead of its official release in December, Peri aims to transform the often misunderstood and confusing experience of perimenopause into actionable insights for women.

Understanding Perimenopause

Perimenopause, a transitional phase leading up to menopause, typically affects women in their early to mid-40s. This stage can bring a whirlwind of physical and emotional changes, including hot flashes, night sweats, mood swings, and sleep disturbances. Despite affecting over a billion women globally, conversation around perimenopause remains limited, often dismissed or inadequately addressed by healthcare providers.

Heidi Davis, CEO and Co-Founder of IdentifyHer, stresses the importance of data and understanding during this critical life stage. “Seventy-five percent of women experience disruptive symptoms during perimenopause, and yet it is often treated as a mystery. Women deserve data and support to manage their health effectively during this time,” she emphasizes.

The Technology Behind Peri

Peri is powered by state-of-the-art biosensing technology combined with AI analytics, designed to track physiological signals passively. It continuously monitors various symptoms throughout the menstrual cycle, helping women identify patterns and interrelationships in their experiences. This method provides a clear overview of their condition, enabling informed decisions about managing symptoms—whether it be lifestyle changes, targeted interventions, or seeking professional help.

For too long, women have relied on self-reporting to communicate their symptoms, which can be inconsistent and subjective. Peri addresses this gap by providing reliable data that can be shared with healthcare professionals, fostering meaningful conversations about treatment options.

Empowering Women with Knowledge

The launch of Peri represents a significant step towards closing the gender health data gap. The wearable device not only aims to demystify perimenopause but also empowers women to actively engage with their health care. “Our goal is to reassure women they are not alone in their experiences and that proactive steps towards health are entirely possible,” explains Donal O’Gorman, COO and Co-Founder of IdentifyHer.

Peri’s launch comes at a time when awareness surrounding women’s health, particularly in the context of perimenopause, is critically needed. Current research highlights that many women seeking help for their symptoms encounter obstacles in obtaining adequate treatment. Alarmingly, statistics reveal that 70% of women consulting healthcare professionals for perimenopause symptoms receive little or no support, often due to insufficient training and poor diagnostic understanding among clinicians.

With a price tag of $449, Peri is also FSA and HSA eligible, making it an accessible option for many. Those interested can place their pre-orders at myperi.co, with deliveries set to commence in December 2025.

Conclusion

The introduction of Peri marks a pivotal moment in women's health technology. With its ability to detect, decode, and interpret perimenopausal symptoms, this innovative device represents a new paradigm in healthcare. By harnessing the power of technology and data, IdentifyHer is leading the charge towards a future where women can take charge of their health with confidence and clarity.

For more information about this revolutionary device and to secure one for yourself, visit myperi.co.

About IdentifyHer: Founded in 2021 by Heidi Davis and Donal O’Gorman, IdentifyHer is an AI-driven women's health company committed to addressing the gender health data gap, enhancing the well-being of women during significant life changes like perimenopause.